Opzelura On Trac Commercial Bridge Program

Funded
About
The Opzelura On Trac Commercial Bridge Program is designed for patients who have been prescribed Opzelura, providing them with continuous access to their medication even if they face insurance hurdles. This program specifically aids those with a prior authorization denial, allowing them to receive Opzelura while appeals are being processed, ensuring uninterrupted treatment.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Program Requirements
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible commercially insured patients who have received a PA denial may be able to receive a limited quantity while HCP files an appeal
After a prior authorization denial from the patient's health plan has been received, HCP should complete and fax the Prescription and Enrollment Form to 8778013840
For assistance or additional information, call 8009321720, Monday through Friday, 8 am–8 pm ET
Other Programs

Assistance Fund: Atopic Dermatitis: Waitlist

Commercially Insured
Medicare / Medicaid

IncyteCARES for Opzelura Patient Assistance Program

Medicare / Medicaid
Underinsured
Uninsured
Other Tools for Opzelura